La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.

Identifieur interne : 000C32 ( Ncbi/Curation ); précédent : 000C31; suivant : 000C33

Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.

Auteurs : Sylvie Bastuji-Garin [France] ; Pascal Joly ; Pauline Lemordant ; Agnès Sparsa ; Christophe Bedane ; Emmanuel Delaporte ; Jean-Claude Roujeau ; Philippe Bernard ; Jean-Claude Guillaume ; Saskia Ingen-Housz-Oro ; Hervé Maillard ; Catherine Pauwels ; Catherine Picard-Dahan ; Yes Dutronc ; Marie-Aleth Richard

Source :

RBID : pubmed:20944650

Descripteurs français

English descriptors

Abstract

A rise in the incidence of bullous pemphigoid (BP) was documented recently in Europe, and the main risk factors for BP remain unknown. We conducted a multicenter case-control study to evaluate risk factors for BP. We identified 201 incident BP cases and 345 controls individually matched for age, gender, center, and place of residence (home, nursing home, or extended-care facility). We used univariate and multivariate logistic regression analyses to compare drugs used for over 3 months, comorbidities, and physical and cognitive impairments between cases and controls. Mean age of BP patients was 84.2 (±8.7) years. Factors independently associated with BP by multivariate analysis were major cognitive impairment (odds ratio (OR), 2.19; 95% confidence interval (95% CI), 1.24-3.87), bedridden condition (OR, 2.19; 95% CI, 1.23-3.89), Parkinson's disease (OR, 2.16; 95% CI, 1.09-4.27), unipolar or bipolar disorder (OR, 5.25; 95% CI, 1.21-22.86), and chronic use of spironolactone (OR, 2.30; 95% CI, 1.20-4.46) or phenothiazines with aliphatic side chains (OR, 3.70; 95% CI, 1.21-11.34). Chronic analgesic use was associated with a lower risk of BP (OR, 0.49; 95% CI, 0.30-0.81). Thus, risk factors for BP include neurological disorders, particularly dementia and Parkinson's disease, psychiatric disorders (unipolar and bipolar disorders), bedridden condition, and chronic use of several drugs.

DOI: 10.1038/jid.2010.301
PubMed: 20944650

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:20944650

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.</title>
<author>
<name sortKey="Bastuji Garin, Sylvie" sort="Bastuji Garin, Sylvie" uniqKey="Bastuji Garin S" first="Sylvie" last="Bastuji-Garin">Sylvie Bastuji-Garin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Faculté de Médecine, LIC EA4393, Université Paris-Est, Créteil, France. sylvie.bastuji-garin@hmn.aphp.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de Médecine, LIC EA4393, Université Paris-Est, Créteil</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Créteil</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name>
</author>
<author>
<name sortKey="Lemordant, Pauline" sort="Lemordant, Pauline" uniqKey="Lemordant P" first="Pauline" last="Lemordant">Pauline Lemordant</name>
</author>
<author>
<name sortKey="Sparsa, Agnes" sort="Sparsa, Agnes" uniqKey="Sparsa A" first="Agnès" last="Sparsa">Agnès Sparsa</name>
</author>
<author>
<name sortKey="Bedane, Christophe" sort="Bedane, Christophe" uniqKey="Bedane C" first="Christophe" last="Bedane">Christophe Bedane</name>
</author>
<author>
<name sortKey="Delaporte, Emmanuel" sort="Delaporte, Emmanuel" uniqKey="Delaporte E" first="Emmanuel" last="Delaporte">Emmanuel Delaporte</name>
</author>
<author>
<name sortKey="Roujeau, Jean Claude" sort="Roujeau, Jean Claude" uniqKey="Roujeau J" first="Jean-Claude" last="Roujeau">Jean-Claude Roujeau</name>
</author>
<author>
<name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name>
</author>
<author>
<name sortKey="Guillaume, Jean Claude" sort="Guillaume, Jean Claude" uniqKey="Guillaume J" first="Jean-Claude" last="Guillaume">Jean-Claude Guillaume</name>
</author>
<author>
<name sortKey="Ingen Housz Oro, Saskia" sort="Ingen Housz Oro, Saskia" uniqKey="Ingen Housz Oro S" first="Saskia" last="Ingen-Housz-Oro">Saskia Ingen-Housz-Oro</name>
</author>
<author>
<name sortKey="Maillard, Herve" sort="Maillard, Herve" uniqKey="Maillard H" first="Hervé" last="Maillard">Hervé Maillard</name>
</author>
<author>
<name sortKey="Pauwels, Catherine" sort="Pauwels, Catherine" uniqKey="Pauwels C" first="Catherine" last="Pauwels">Catherine Pauwels</name>
</author>
<author>
<name sortKey="Picard Dahan, Catherine" sort="Picard Dahan, Catherine" uniqKey="Picard Dahan C" first="Catherine" last="Picard-Dahan">Catherine Picard-Dahan</name>
</author>
<author>
<name sortKey="Dutronc, Yes" sort="Dutronc, Yes" uniqKey="Dutronc Y" first="Yes" last="Dutronc">Yes Dutronc</name>
</author>
<author>
<name sortKey="Richard, Marie Aleth" sort="Richard, Marie Aleth" uniqKey="Richard M" first="Marie-Aleth" last="Richard">Marie-Aleth Richard</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:20944650</idno>
<idno type="pmid">20944650</idno>
<idno type="doi">10.1038/jid.2010.301</idno>
<idno type="wicri:Area/PubMed/Corpus">000993</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000993</idno>
<idno type="wicri:Area/PubMed/Curation">000953</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000953</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000953</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000953</idno>
<idno type="wicri:Area/Ncbi/Merge">000C32</idno>
<idno type="wicri:Area/Ncbi/Curation">000C32</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.</title>
<author>
<name sortKey="Bastuji Garin, Sylvie" sort="Bastuji Garin, Sylvie" uniqKey="Bastuji Garin S" first="Sylvie" last="Bastuji-Garin">Sylvie Bastuji-Garin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Faculté de Médecine, LIC EA4393, Université Paris-Est, Créteil, France. sylvie.bastuji-garin@hmn.aphp.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de Médecine, LIC EA4393, Université Paris-Est, Créteil</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Créteil</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name>
</author>
<author>
<name sortKey="Lemordant, Pauline" sort="Lemordant, Pauline" uniqKey="Lemordant P" first="Pauline" last="Lemordant">Pauline Lemordant</name>
</author>
<author>
<name sortKey="Sparsa, Agnes" sort="Sparsa, Agnes" uniqKey="Sparsa A" first="Agnès" last="Sparsa">Agnès Sparsa</name>
</author>
<author>
<name sortKey="Bedane, Christophe" sort="Bedane, Christophe" uniqKey="Bedane C" first="Christophe" last="Bedane">Christophe Bedane</name>
</author>
<author>
<name sortKey="Delaporte, Emmanuel" sort="Delaporte, Emmanuel" uniqKey="Delaporte E" first="Emmanuel" last="Delaporte">Emmanuel Delaporte</name>
</author>
<author>
<name sortKey="Roujeau, Jean Claude" sort="Roujeau, Jean Claude" uniqKey="Roujeau J" first="Jean-Claude" last="Roujeau">Jean-Claude Roujeau</name>
</author>
<author>
<name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name>
</author>
<author>
<name sortKey="Guillaume, Jean Claude" sort="Guillaume, Jean Claude" uniqKey="Guillaume J" first="Jean-Claude" last="Guillaume">Jean-Claude Guillaume</name>
</author>
<author>
<name sortKey="Ingen Housz Oro, Saskia" sort="Ingen Housz Oro, Saskia" uniqKey="Ingen Housz Oro S" first="Saskia" last="Ingen-Housz-Oro">Saskia Ingen-Housz-Oro</name>
</author>
<author>
<name sortKey="Maillard, Herve" sort="Maillard, Herve" uniqKey="Maillard H" first="Hervé" last="Maillard">Hervé Maillard</name>
</author>
<author>
<name sortKey="Pauwels, Catherine" sort="Pauwels, Catherine" uniqKey="Pauwels C" first="Catherine" last="Pauwels">Catherine Pauwels</name>
</author>
<author>
<name sortKey="Picard Dahan, Catherine" sort="Picard Dahan, Catherine" uniqKey="Picard Dahan C" first="Catherine" last="Picard-Dahan">Catherine Picard-Dahan</name>
</author>
<author>
<name sortKey="Dutronc, Yes" sort="Dutronc, Yes" uniqKey="Dutronc Y" first="Yes" last="Dutronc">Yes Dutronc</name>
</author>
<author>
<name sortKey="Richard, Marie Aleth" sort="Richard, Marie Aleth" uniqKey="Richard M" first="Marie-Aleth" last="Richard">Marie-Aleth Richard</name>
</author>
</analytic>
<series>
<title level="j">The Journal of investigative dermatology</title>
<idno type="eISSN">1523-1747</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antipsychotic Agents (adverse effects)</term>
<term>Bed Rest (adverse effects)</term>
<term>Bipolar Disorder (complications)</term>
<term>Case-Control Studies</term>
<term>Cognition Disorders (complications)</term>
<term>Female</term>
<term>France (epidemiology)</term>
<term>Humans</term>
<term>Male</term>
<term>Multivariate Analysis</term>
<term>Nervous System Diseases (complications)</term>
<term>Parkinson Disease (complications)</term>
<term>Pemphigoid, Bullous (epidemiology)</term>
<term>Phenothiazines (adverse effects)</term>
<term>Prospective Studies</term>
<term>Risk Factors</term>
<term>Spironolactone (adverse effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antipsychotic Agents</term>
<term>Phenothiazines</term>
<term>Spironolactone</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Bed Rest</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Bipolar Disorder</term>
<term>Cognition Disorders</term>
<term>Nervous System Diseases</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Pemphigoid, Bullous</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Multivariate Analysis</term>
<term>Prospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A rise in the incidence of bullous pemphigoid (BP) was documented recently in Europe, and the main risk factors for BP remain unknown. We conducted a multicenter case-control study to evaluate risk factors for BP. We identified 201 incident BP cases and 345 controls individually matched for age, gender, center, and place of residence (home, nursing home, or extended-care facility). We used univariate and multivariate logistic regression analyses to compare drugs used for over 3 months, comorbidities, and physical and cognitive impairments between cases and controls. Mean age of BP patients was 84.2 (±8.7) years. Factors independently associated with BP by multivariate analysis were major cognitive impairment (odds ratio (OR), 2.19; 95% confidence interval (95% CI), 1.24-3.87), bedridden condition (OR, 2.19; 95% CI, 1.23-3.89), Parkinson's disease (OR, 2.16; 95% CI, 1.09-4.27), unipolar or bipolar disorder (OR, 5.25; 95% CI, 1.21-22.86), and chronic use of spironolactone (OR, 2.30; 95% CI, 1.20-4.46) or phenothiazines with aliphatic side chains (OR, 3.70; 95% CI, 1.21-11.34). Chronic analgesic use was associated with a lower risk of BP (OR, 0.49; 95% CI, 0.30-0.81). Thus, risk factors for BP include neurological disorders, particularly dementia and Parkinson's disease, psychiatric disorders (unipolar and bipolar disorders), bedridden condition, and chronic use of several drugs.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C32 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000C32 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:20944650
   |texte=   Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:20944650" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024